nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—SLC22A1—prostate cancer	0.125	0.527	CbGaD
Probenecid—SLC22A10—Conjugated Estrogens—prostate cancer	0.0692	0.126	CbGbCtD
Probenecid—CYP2C19—prostate cancer	0.0688	0.289	CbGaD
Probenecid—ABCC11—Conjugated Estrogens—prostate cancer	0.046	0.0838	CbGbCtD
Probenecid—CYP3A4—prostate cancer	0.0437	0.184	CbGaD
Probenecid—SLC10A1—Ethinyl Estradiol—prostate cancer	0.0311	0.0566	CbGbCtD
Probenecid—SLC10A1—Conjugated Estrogens—prostate cancer	0.0228	0.0416	CbGbCtD
Probenecid—SLCO1C1—Conjugated Estrogens—prostate cancer	0.0202	0.0368	CbGbCtD
Probenecid—SLCO1C1—Estradiol—prostate cancer	0.0177	0.0323	CbGbCtD
Probenecid—ABCC1—Abiraterone—prostate cancer	0.0165	0.03	CbGbCtD
Probenecid—ABCC6—Etoposide—prostate cancer	0.0151	0.0276	CbGbCtD
Probenecid—ABCC3—Conjugated Estrogens—prostate cancer	0.0127	0.0231	CbGbCtD
Probenecid—SLCO1A2—Estrone—prostate cancer	0.0106	0.0194	CbGbCtD
Probenecid—SLC22A11—Conjugated Estrogens—prostate cancer	0.0104	0.019	CbGbCtD
Probenecid—ABCC6—Doxorubicin—prostate cancer	0.0103	0.0188	CbGbCtD
Probenecid—ABCC4—Conjugated Estrogens—prostate cancer	0.0097	0.0177	CbGbCtD
Probenecid—SLC22A11—Estradiol—prostate cancer	0.00915	0.0167	CbGbCtD
Probenecid—ABCC2—Ethinyl Estradiol—prostate cancer	0.00786	0.0143	CbGbCtD
Probenecid—ABCC1—Conjugated Estrogens—prostate cancer	0.00779	0.0142	CbGbCtD
Probenecid—ALB—Abiraterone—prostate cancer	0.0076	0.0138	CbGbCtD
Probenecid—ABCC3—Etoposide—prostate cancer	0.00728	0.0132	CbGbCtD
Probenecid—CYP2C8—Nilutamide—prostate cancer	0.00709	0.0129	CbGbCtD
Probenecid—ABCC1—Mitoxantrone—prostate cancer	0.00708	0.0129	CbGbCtD
Probenecid—SLCO1A2—Conjugated Estrogens—prostate cancer	0.00696	0.0127	CbGbCtD
Probenecid—SLC22A2—Estradiol—prostate cancer	0.0062	0.0113	CbGbCtD
Probenecid—SLCO1A2—Estradiol—prostate cancer	0.00611	0.0111	CbGbCtD
Probenecid—SLC22A8—Conjugated Estrogens—prostate cancer	0.00606	0.011	CbGbCtD
Probenecid—CYP2C19—Nilutamide—prostate cancer	0.00595	0.0108	CbGbCtD
Probenecid—CYP2C19—Bicalutamide—prostate cancer	0.00595	0.0108	CbGbCtD
Probenecid—CYP2C8—Abiraterone—prostate cancer	0.00587	0.0107	CbGbCtD
Probenecid—ABCC2—Conjugated Estrogens—prostate cancer	0.00577	0.0105	CbGbCtD
Probenecid—ABCC1—Epirubicin—prostate cancer	0.00573	0.0104	CbGbCtD
Probenecid—ALB—Estrone—prostate cancer	0.00549	0.01	CbGbCtD
Probenecid—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00547	0.00996	CbGbCtD
Probenecid—SLC22A1—Estradiol—prostate cancer	0.00539	0.00981	CbGbCtD
Probenecid—SLC22A8—Estradiol—prostate cancer	0.00532	0.00969	CbGbCtD
Probenecid—SLCO1A2—Prednisone—prostate cancer	0.00525	0.00956	CbGbCtD
Probenecid—SLC22A7—Docetaxel—prostate cancer	0.00521	0.00948	CbGbCtD
Probenecid—ABCC3—Doxorubicin—prostate cancer	0.00496	0.00904	CbGbCtD
Probenecid—CYP2C9—Nilutamide—prostate cancer	0.00494	0.009	CbGbCtD
Probenecid—CYP2C9—Bicalutamide—prostate cancer	0.00494	0.009	CbGbCtD
Probenecid—CYP2C19—Flutamide—prostate cancer	0.00493	0.00897	CbGbCtD
Probenecid—ABCC1—Etoposide—prostate cancer	0.00447	0.00813	CbGbCtD
Probenecid—ABCB1—Estramustine—prostate cancer	0.00446	0.00812	CbGbCtD
Probenecid—CYP2C8—Cabazitaxel—prostate cancer	0.00434	0.00791	CbGbCtD
Probenecid—SLC22A6—Conjugated Estrogens—prostate cancer	0.00422	0.00769	CbGbCtD
Probenecid—ABCC1—Docetaxel—prostate cancer	0.00409	0.00744	CbGbCtD
Probenecid—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00378	0.00689	CbGbCtD
Probenecid—ABCC2—Etoposide—prostate cancer	0.00331	0.00602	CbGbCtD
Probenecid—ALB—Estradiol—prostate cancer	0.00316	0.00575	CbGbCtD
Probenecid—ABCC1—Doxorubicin—prostate cancer	0.00305	0.00555	CbGbCtD
Probenecid—ABCC2—Docetaxel—prostate cancer	0.00303	0.00551	CbGbCtD
Probenecid—CYP2C9—Estrone—prostate cancer	0.00296	0.00539	CbGbCtD
Probenecid—ABCB1—Cabazitaxel—prostate cancer	0.00294	0.00535	CbGbCtD
Probenecid—CYP3A4—Bicalutamide—prostate cancer	0.00287	0.00523	CbGbCtD
Probenecid—ABCB1—Estrone—prostate cancer	0.00287	0.00523	CbGbCtD
Probenecid—ALB—Prednisone—prostate cancer	0.00271	0.00494	CbGbCtD
Probenecid—CYP3A4—Estramustine—prostate cancer	0.00267	0.00487	CbGbCtD
Probenecid—ABCB1—Ethinyl Estradiol—prostate cancer	0.00256	0.00466	CbGbCtD
Probenecid—CYP2C8—Estradiol—prostate cancer	0.00244	0.00444	CbGbCtD
Probenecid—CYP3A4—Flutamide—prostate cancer	0.00238	0.00434	CbGbCtD
Probenecid—CYP3A4—Abiraterone—prostate cancer	0.00238	0.00434	CbGbCtD
Probenecid—ABCC2—Doxorubicin—prostate cancer	0.00226	0.00411	CbGbCtD
Probenecid—CYP2C9—Capecitabine—prostate cancer	0.00224	0.00409	CbGbCtD
Probenecid—PANX1—prostate gland—prostate cancer	0.00209	0.0452	CbGeAlD
Probenecid—CYP2C19—Estradiol—prostate cancer	0.00205	0.00373	CbGbCtD
Probenecid—SLC2A9—prostate gland—prostate cancer	0.0019	0.041	CbGeAlD
Probenecid—ABCB1—Conjugated Estrogens—prostate cancer	0.00188	0.00342	CbGbCtD
Probenecid—SLC22A12—renal system—prostate cancer	0.00188	0.0407	CbGeAlD
Probenecid—PANX1—seminal vesicle—prostate cancer	0.00177	0.0383	CbGeAlD
Probenecid—CYP3A4—Cabazitaxel—prostate cancer	0.00176	0.00321	CbGbCtD
Probenecid—CYP2C19—Prednisone—prostate cancer	0.00176	0.0032	CbGbCtD
Probenecid—CYP3A4—Estrone—prostate cancer	0.00172	0.00314	CbGbCtD
Probenecid—ABCB1—Mitoxantrone—prostate cancer	0.00171	0.00311	CbGbCtD
Probenecid—CYP2C9—Estradiol—prostate cancer	0.0017	0.0031	CbGbCtD
Probenecid—ABCB1—Estradiol—prostate cancer	0.00165	0.00301	CbGbCtD
Probenecid—SLC2A9—seminal vesicle—prostate cancer	0.0016	0.0347	CbGeAlD
Probenecid—CYP2C8—Etoposide—prostate cancer	0.00159	0.0029	CbGbCtD
Probenecid—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00153	0.00279	CbGbCtD
Probenecid—SLC22A8—urine—prostate cancer	0.0015	0.0324	CbGeAlD
Probenecid—ABCB1—Prednisone—prostate cancer	0.00142	0.00258	CbGbCtD
Probenecid—PANX1—urethra—prostate cancer	0.0014	0.0303	CbGeAlD
Probenecid—ABCC6—Podofilox—Etoposide—prostate cancer	0.00129	1	CbGdCrCtD
Probenecid—SLC2A9—renal system—prostate cancer	0.00129	0.028	CbGeAlD
Probenecid—CYP2C19—urine—prostate cancer	0.00126	0.0272	CbGeAlD
Probenecid—CYP3A4—Conjugated Estrogens—prostate cancer	0.00113	0.00205	CbGbCtD
Probenecid—SLC16A7—prostate gland—prostate cancer	0.00112	0.0242	CbGeAlD
Probenecid—ABCB1—Etoposide—prostate cancer	0.00108	0.00196	CbGbCtD
Probenecid—SLC10A1—prostate gland—prostate cancer	0.00104	0.0226	CbGeAlD
Probenecid—CYP3A4—Mitoxantrone—prostate cancer	0.00102	0.00186	CbGbCtD
Probenecid—CYP3A4—Estradiol—prostate cancer	0.000989	0.0018	CbGbCtD
Probenecid—ABCB1—Docetaxel—prostate cancer	0.000986	0.0018	CbGbCtD
Probenecid—CYP2C9—urine—prostate cancer	0.000974	0.0211	CbGeAlD
Probenecid—PANX1—testis—prostate cancer	0.000921	0.0199	CbGeAlD
Probenecid—SLC10A1—seminal vesicle—prostate cancer	0.000883	0.0191	CbGeAlD
Probenecid—ABCC11—testis—prostate cancer	0.000883	0.0191	CbGeAlD
Probenecid—CYP3A4—Prednisone—prostate cancer	0.000851	0.00155	CbGbCtD
Probenecid—SLC2A9—testis—prostate cancer	0.000835	0.0181	CbGeAlD
Probenecid—ABCC6—renal system—prostate cancer	0.000785	0.017	CbGeAlD
Probenecid—ABCC5—prostate gland—prostate cancer	0.000782	0.0169	CbGeAlD
Probenecid—SLC16A7—urethra—prostate cancer	0.000749	0.0162	CbGeAlD
Probenecid—CYP3A4—urine—prostate cancer	0.000743	0.0161	CbGeAlD
Probenecid—ABCB1—Doxorubicin—prostate cancer	0.000735	0.00134	CbGbCtD
Probenecid—SLC10A1—renal system—prostate cancer	0.000712	0.0154	CbGeAlD
Probenecid—SLC16A1—prostate gland—prostate cancer	0.000712	0.0154	CbGeAlD
Probenecid—SLCO1C1—renal system—prostate cancer	0.000669	0.0145	CbGeAlD
Probenecid—PANX1—lymph node—prostate cancer	0.000668	0.0144	CbGeAlD
Probenecid—ABCC3—prostate gland—prostate cancer	0.000657	0.0142	CbGeAlD
Probenecid—SLC22A11—renal system—prostate cancer	0.00065	0.0141	CbGeAlD
Probenecid—CYP3A4—Etoposide—prostate cancer	0.000646	0.00118	CbGbCtD
Probenecid—SLC22A7—renal system—prostate cancer	0.000635	0.0137	CbGeAlD
Probenecid—SLC2A9—lymph node—prostate cancer	0.000605	0.0131	CbGeAlD
Probenecid—CYP3A4—Docetaxel—prostate cancer	0.000591	0.00108	CbGbCtD
Probenecid—SLC22A2—renal system—prostate cancer	0.000565	0.0122	CbGeAlD
Probenecid—ABCC4—prostate gland—prostate cancer	0.000542	0.0117	CbGeAlD
Probenecid—SLC22A8—prostate gland—prostate cancer	0.000538	0.0116	CbGeAlD
Probenecid—ABCC2—prostate gland—prostate cancer	0.000525	0.0114	CbGeAlD
Probenecid—SLC16A1—epithelium—prostate cancer	0.000523	0.0113	CbGeAlD
Probenecid—SLC16A7—testis—prostate cancer	0.000493	0.0107	CbGeAlD
Probenecid—SLC16A1—renal system—prostate cancer	0.000485	0.0105	CbGeAlD
Probenecid—Procainamide—DNMT1—prostate cancer	0.00047	0.227	CrCbGaD
Probenecid—ABCC1—prostate gland—prostate cancer	0.000462	0.01	CbGeAlD
Probenecid—SLC10A1—testis—prostate cancer	0.00046	0.00996	CbGeAlD
Probenecid—ABCC3—renal system—prostate cancer	0.000448	0.00969	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—prostate cancer	0.00044	0.000802	CbGbCtD
Probenecid—SLCO1C1—testis—prostate cancer	0.000433	0.00936	CbGeAlD
Probenecid—Tolbutamide—CYP2C18—prostate cancer	0.000414	0.2	CrCbGaD
Probenecid—SLC22A7—testis—prostate cancer	0.00041	0.00887	CbGeAlD
Probenecid—SLC22A5—prostate gland—prostate cancer	0.000407	0.0088	CbGeAlD
Probenecid—ABCC5—bone marrow—prostate cancer	0.000403	0.00873	CbGeAlD
Probenecid—SLC22A1—renal system—prostate cancer	0.000399	0.00863	CbGeAlD
Probenecid—ABCC1—seminal vesicle—prostate cancer	0.000391	0.00846	CbGeAlD
Probenecid—SLCO1A2—renal system—prostate cancer	0.000384	0.00831	CbGeAlD
Probenecid—ABCC4—renal system—prostate cancer	0.00037	0.008	CbGeAlD
Probenecid—SLC22A8—renal system—prostate cancer	0.000367	0.00794	CbGeAlD
Probenecid—ABCC2—renal system—prostate cancer	0.000358	0.00774	CbGeAlD
Probenecid—SLC16A7—lymph node—prostate cancer	0.000357	0.00773	CbGeAlD
Probenecid—ABCC5—testis—prostate cancer	0.000345	0.00746	CbGeAlD
Probenecid—SLC22A5—seminal vesicle—prostate cancer	0.000344	0.00744	CbGeAlD
Probenecid—SLC16A1—testis—prostate cancer	0.000314	0.00679	CbGeAlD
Probenecid—SLCO1C1—lymph node—prostate cancer	0.000314	0.00679	CbGeAlD
Probenecid—ABCC1—urethra—prostate cancer	0.00031	0.0067	CbGeAlD
Probenecid—Procainamide—SLC22A3—prostate cancer	0.000307	0.149	CrCbGaD
Probenecid—ABCC3—testis—prostate cancer	0.000289	0.00626	CbGeAlD
Probenecid—Vomiting—Estramustine—prostate cancer	0.000289	0.00415	CcSEcCtD
Probenecid—Dizziness—Estrone—prostate cancer	0.000288	0.00412	CcSEcCtD
Probenecid—Dermatitis—Estramustine—prostate cancer	0.000287	0.00411	CcSEcCtD
Probenecid—Urticaria—Degarelix—prostate cancer	0.000287	0.00411	CcSEcCtD
Probenecid—Pruritus—Nilutamide—prostate cancer	0.000286	0.0041	CcSEcCtD
Probenecid—Body temperature increased—Degarelix—prostate cancer	0.000285	0.00409	CcSEcCtD
Probenecid—Headache—Estramustine—prostate cancer	0.000285	0.00409	CcSEcCtD
Probenecid—Pruritus—Flutamide—prostate cancer	0.000284	0.00408	CcSEcCtD
Probenecid—Vomiting—Abiraterone—prostate cancer	0.000281	0.00403	CcSEcCtD
Probenecid—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.00028	0.00401	CcSEcCtD
Probenecid—ABCC4—bone marrow—prostate cancer	0.000279	0.00605	CbGeAlD
Probenecid—Dermatitis—Abiraterone—prostate cancer	0.000278	0.00399	CcSEcCtD
Probenecid—Procainamide—ACHE—prostate cancer	0.000278	0.135	CrCbGaD
Probenecid—Anorexia—Bicalutamide—prostate cancer	0.000278	0.00399	CcSEcCtD
Probenecid—SLC22A5—renal system—prostate cancer	0.000277	0.006	CbGeAlD
Probenecid—Vomiting—Estrone—prostate cancer	0.000276	0.00397	CcSEcCtD
Probenecid—Dermatitis—Estrone—prostate cancer	0.000274	0.00393	CcSEcCtD
Probenecid—Headache—Estrone—prostate cancer	0.000272	0.00391	CcSEcCtD
Probenecid—SLC22A5—urethra—prostate cancer	0.000272	0.00589	CbGeAlD
Probenecid—Nausea—Estramustine—prostate cancer	0.00027	0.00388	CcSEcCtD
Probenecid—Body temperature increased—Cabazitaxel—prostate cancer	0.000269	0.00385	CcSEcCtD
Probenecid—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000268	0.00385	CcSEcCtD
Probenecid—CYP2C8—renal system—prostate cancer	0.000268	0.00581	CbGeAlD
Probenecid—Erythema multiforme—Conjugated Estrogens—prostate cancer	0.000267	0.00383	CcSEcCtD
Probenecid—Dizziness—Nilutamide—prostate cancer	0.000267	0.00383	CcSEcCtD
Probenecid—Dizziness—Flutamide—prostate cancer	0.000266	0.00381	CcSEcCtD
Probenecid—Hypersensitivity—Degarelix—prostate cancer	0.000266	0.00381	CcSEcCtD
Probenecid—Pollakiuria—Estradiol—prostate cancer	0.000261	0.00375	CcSEcCtD
Probenecid—Nausea—Estrone—prostate cancer	0.000258	0.0037	CcSEcCtD
Probenecid—Vomiting—Nilutamide—prostate cancer	0.000257	0.00368	CcSEcCtD
Probenecid—Vomiting—Flutamide—prostate cancer	0.000256	0.00367	CcSEcCtD
Probenecid—Pruritus—Degarelix—prostate cancer	0.000255	0.00366	CcSEcCtD
Probenecid—Dermatitis—Nilutamide—prostate cancer	0.000254	0.00365	CcSEcCtD
Probenecid—Decreased appetite—Bicalutamide—prostate cancer	0.000253	0.00364	CcSEcCtD
Probenecid—Dermatitis—Flutamide—prostate cancer	0.000253	0.00363	CcSEcCtD
Probenecid—Headache—Nilutamide—prostate cancer	0.000253	0.00363	CcSEcCtD
Probenecid—Alopecia—Goserelin—prostate cancer	0.000252	0.00362	CcSEcCtD
Probenecid—Headache—Flutamide—prostate cancer	0.000252	0.00361	CcSEcCtD
Probenecid—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000251	0.0036	CcSEcCtD
Probenecid—Hypersensitivity—Cabazitaxel—prostate cancer	0.00025	0.00359	CcSEcCtD
Probenecid—Alopecia—Conjugated Estrogens—prostate cancer	0.00025	0.00358	CcSEcCtD
Probenecid—ABCC5—lymph node—prostate cancer	0.00025	0.00541	CbGeAlD
Probenecid—Pain—Bicalutamide—prostate cancer	0.000249	0.00358	CcSEcCtD
Probenecid—SLCO1A2—testis—prostate cancer	0.000248	0.00537	CbGeAlD
Probenecid—ALB—testis—prostate cancer	0.000247	0.00534	CbGeAlD
Probenecid—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000241	0.00346	CcSEcCtD
Probenecid—Haematuria—Estradiol—prostate cancer	0.00024	0.00345	CcSEcCtD
Probenecid—Nausea—Nilutamide—prostate cancer	0.00024	0.00344	CcSEcCtD
Probenecid—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000239	0.00343	CcSEcCtD
Probenecid—ABCC4—testis—prostate cancer	0.000239	0.00517	CbGeAlD
Probenecid—Nausea—Flutamide—prostate cancer	0.000239	0.00343	CcSEcCtD
Probenecid—Dizziness—Degarelix—prostate cancer	0.000239	0.00342	CcSEcCtD
Probenecid—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000238	0.00341	CcSEcCtD
Probenecid—Urticaria—Bicalutamide—prostate cancer	0.000232	0.00332	CcSEcCtD
Probenecid—ABCC2—testis—prostate cancer	0.000231	0.005	CbGeAlD
Probenecid—Body temperature increased—Bicalutamide—prostate cancer	0.00023	0.00331	CcSEcCtD
Probenecid—Anaemia—Goserelin—prostate cancer	0.00023	0.00329	CcSEcCtD
Probenecid—Vomiting—Degarelix—prostate cancer	0.000229	0.00329	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Etoposide—prostate cancer	0.000228	0.00327	CcSEcCtD
Probenecid—SLC16A1—lymph node—prostate cancer	0.000227	0.00492	CbGeAlD
Probenecid—Dermatitis—Degarelix—prostate cancer	0.000227	0.00326	CcSEcCtD
Probenecid—Headache—Degarelix—prostate cancer	0.000226	0.00324	CcSEcCtD
Probenecid—Haemolytic anaemia—Capecitabine—prostate cancer	0.000226	0.00324	CcSEcCtD
Probenecid—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000225	0.00323	CcSEcCtD
Probenecid—Dizziness—Cabazitaxel—prostate cancer	0.000225	0.00322	CcSEcCtD
Probenecid—Haematuria—Mitoxantrone—prostate cancer	0.000224	0.00321	CcSEcCtD
Probenecid—Leukopenia—Goserelin—prostate cancer	0.000222	0.00319	CcSEcCtD
Probenecid—Procainamide—SLC22A1—prostate cancer	0.00022	0.107	CrCbGaD
Probenecid—Vomiting—Cabazitaxel—prostate cancer	0.000216	0.0031	CcSEcCtD
Probenecid—Hypersensitivity—Bicalutamide—prostate cancer	0.000215	0.00308	CcSEcCtD
Probenecid—Nausea—Degarelix—prostate cancer	0.000214	0.00307	CcSEcCtD
Probenecid—Erythema multiforme—Estradiol—prostate cancer	0.000214	0.00307	CcSEcCtD
Probenecid—Headache—Cabazitaxel—prostate cancer	0.000213	0.00305	CcSEcCtD
Probenecid—Flushing—Estradiol—prostate cancer	0.00021	0.00301	CcSEcCtD
Probenecid—ABCC3—lymph node—prostate cancer	0.00021	0.00454	CbGeAlD
Probenecid—Pruritus—Bicalutamide—prostate cancer	0.000206	0.00296	CcSEcCtD
Probenecid—ABCC1—testis—prostate cancer	0.000204	0.00441	CbGeAlD
Probenecid—Anaphylactic shock—Goserelin—prostate cancer	0.000203	0.00291	CcSEcCtD
Probenecid—Nausea—Cabazitaxel—prostate cancer	0.000202	0.0029	CcSEcCtD
Probenecid—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000201	0.00288	CcSEcCtD
Probenecid—Alopecia—Estradiol—prostate cancer	0.0002	0.00287	CcSEcCtD
Probenecid—Urticaria—Ethinyl Estradiol—prostate cancer	0.000196	0.00281	CcSEcCtD
Probenecid—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000195	0.00279	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Etoposide—prostate cancer	0.000194	0.00278	CcSEcCtD
Probenecid—Anorexia—Goserelin—prostate cancer	0.000193	0.00277	CcSEcCtD
Probenecid—Dizziness—Bicalutamide—prostate cancer	0.000193	0.00277	CcSEcCtD
Probenecid—Anorexia—Conjugated Estrogens—prostate cancer	0.000192	0.00275	CcSEcCtD
Probenecid—Chlorpropamide—CYP2C19—prostate cancer	0.000191	0.0922	CrCbGaD
Probenecid—Toxic epidermal necrolysis—Docetaxel—prostate cancer	0.00019	0.00272	CcSEcCtD
Probenecid—ABCB1—prostate gland—prostate cancer	0.000189	0.00409	CbGeAlD
Probenecid—Alopecia—Mitoxantrone—prostate cancer	0.000186	0.00267	CcSEcCtD
Probenecid—Tolbutamide—CYP2C19—prostate cancer	0.000186	0.0899	CrCbGaD
Probenecid—Vomiting—Bicalutamide—prostate cancer	0.000185	0.00266	CcSEcCtD
Probenecid—Aplastic anaemia—Epirubicin—prostate cancer	0.000184	0.00264	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Capecitabine—prostate cancer	0.000184	0.00263	CcSEcCtD
Probenecid—Dermatitis—Bicalutamide—prostate cancer	0.000184	0.00263	CcSEcCtD
Probenecid—Headache—Bicalutamide—prostate cancer	0.000183	0.00262	CcSEcCtD
Probenecid—CYP3A4—renal system—prostate cancer	0.000182	0.00393	CbGeAlD
Probenecid—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000182	0.0026	CcSEcCtD
Probenecid—SLC22A5—testis—prostate cancer	0.000179	0.00388	CbGeAlD
Probenecid—ALB—lymph node—prostate cancer	0.000179	0.00387	CbGeAlD
Probenecid—Decreased appetite—Goserelin—prostate cancer	0.000176	0.00253	CcSEcCtD
Probenecid—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000175	0.0025	CcSEcCtD
Probenecid—Pruritus—Ethinyl Estradiol—prostate cancer	0.000174	0.0025	CcSEcCtD
Probenecid—CYP2C8—testis—prostate cancer	0.000173	0.00375	CbGeAlD
Probenecid—Pain—Goserelin—prostate cancer	0.000173	0.00249	CcSEcCtD
Probenecid—Nausea—Bicalutamide—prostate cancer	0.000173	0.00248	CcSEcCtD
Probenecid—ABCC4—lymph node—prostate cancer	0.000173	0.00375	CbGeAlD
Probenecid—Pain—Conjugated Estrogens—prostate cancer	0.000172	0.00246	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—prostate cancer	0.00017	0.00244	CcSEcCtD
Probenecid—Anaemia—Mitoxantrone—prostate cancer	0.00017	0.00243	CcSEcCtD
Probenecid—ABCC2—lymph node—prostate cancer	0.000168	0.00363	CbGeAlD
Probenecid—Erythema multiforme—Etoposide—prostate cancer	0.000166	0.00238	CcSEcCtD
Probenecid—Leukopenia—Mitoxantrone—prostate cancer	0.000164	0.00236	CcSEcCtD
Probenecid—Dizziness—Ethinyl Estradiol—prostate cancer	0.000163	0.00234	CcSEcCtD
Probenecid—Flushing—Etoposide—prostate cancer	0.000163	0.00233	CcSEcCtD
Probenecid—Urticaria—Goserelin—prostate cancer	0.000161	0.00231	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000161	0.00231	CcSEcCtD
Probenecid—Anaphylactic shock—Estradiol—prostate cancer	0.000161	0.00231	CcSEcCtD
Probenecid—Body temperature increased—Goserelin—prostate cancer	0.00016	0.0023	CcSEcCtD
Probenecid—ABCB1—seminal vesicle—prostate cancer	0.00016	0.00346	CbGeAlD
Probenecid—Urticaria—Conjugated Estrogens—prostate cancer	0.00016	0.00229	CcSEcCtD
Probenecid—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000159	0.00228	CcSEcCtD
Probenecid—Vomiting—Ethinyl Estradiol—prostate cancer	0.000157	0.00225	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000156	0.00224	CcSEcCtD
Probenecid—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000155	0.00223	CcSEcCtD
Probenecid—Alopecia—Etoposide—prostate cancer	0.000155	0.00222	CcSEcCtD
Probenecid—Headache—Ethinyl Estradiol—prostate cancer	0.000154	0.00221	CcSEcCtD
Probenecid—Haematuria—Capecitabine—prostate cancer	0.00015	0.00215	CcSEcCtD
Probenecid—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00015	0.00215	CcSEcCtD
Probenecid—Hypersensitivity—Goserelin—prostate cancer	0.000149	0.00214	CcSEcCtD
Probenecid—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000148	0.00212	CcSEcCtD
Probenecid—ABCC1—lymph node—prostate cancer	0.000148	0.0032	CbGeAlD
Probenecid—Nausea—Ethinyl Estradiol—prostate cancer	0.000146	0.0021	CcSEcCtD
Probenecid—Pruritus—Goserelin—prostate cancer	0.000144	0.00206	CcSEcCtD
Probenecid—Anorexia—Mitoxantrone—prostate cancer	0.000143	0.00205	CcSEcCtD
Probenecid—Pruritus—Conjugated Estrogens—prostate cancer	0.000142	0.00204	CcSEcCtD
Probenecid—Anaemia—Etoposide—prostate cancer	0.000141	0.00202	CcSEcCtD
Probenecid—Decreased appetite—Estradiol—prostate cancer	0.00014	0.002	CcSEcCtD
Probenecid—ABCB1—epithelium—prostate cancer	0.000139	0.003	CbGeAlD
Probenecid—Erythema multiforme—Docetaxel—prostate cancer	0.000138	0.00198	CcSEcCtD
Probenecid—Pain—Estradiol—prostate cancer	0.000138	0.00197	CcSEcCtD
Probenecid—Leukopenia—Etoposide—prostate cancer	0.000137	0.00196	CcSEcCtD
Probenecid—Flushing—Docetaxel—prostate cancer	0.000135	0.00194	CcSEcCtD
Probenecid—Dizziness—Goserelin—prostate cancer	0.000134	0.00192	CcSEcCtD
Probenecid—Erythema multiforme—Capecitabine—prostate cancer	0.000133	0.00191	CcSEcCtD
Probenecid—Dizziness—Conjugated Estrogens—prostate cancer	0.000133	0.00191	CcSEcCtD
Probenecid—Flushing—Capecitabine—prostate cancer	0.000131	0.00188	CcSEcCtD
Probenecid—Decreased appetite—Mitoxantrone—prostate cancer	0.00013	0.00187	CcSEcCtD
Probenecid—SLC22A5—lymph node—prostate cancer	0.00013	0.00281	CbGeAlD
Probenecid—Vomiting—Goserelin—prostate cancer	0.000129	0.00185	CcSEcCtD
Probenecid—Alopecia—Docetaxel—prostate cancer	0.000129	0.00185	CcSEcCtD
Probenecid—ABCB1—renal system—prostate cancer	0.000129	0.00278	CbGeAlD
Probenecid—Pain—Mitoxantrone—prostate cancer	0.000128	0.00184	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000128	0.00184	CcSEcCtD
Probenecid—Dermatitis—Goserelin—prostate cancer	0.000128	0.00183	CcSEcCtD
Probenecid—Vomiting—Conjugated Estrogens—prostate cancer	0.000128	0.00183	CcSEcCtD
Probenecid—Urticaria—Estradiol—prostate cancer	0.000128	0.00183	CcSEcCtD
Probenecid—Body temperature increased—Estradiol—prostate cancer	0.000127	0.00182	CcSEcCtD
Probenecid—Headache—Goserelin—prostate cancer	0.000127	0.00182	CcSEcCtD
Probenecid—Dermatitis—Conjugated Estrogens—prostate cancer	0.000127	0.00182	CcSEcCtD
Probenecid—ABCB1—urethra—prostate cancer	0.000126	0.00274	CbGeAlD
Probenecid—Headache—Conjugated Estrogens—prostate cancer	0.000126	0.00181	CcSEcCtD
Probenecid—Alopecia—Capecitabine—prostate cancer	0.000125	0.00179	CcSEcCtD
Probenecid—Anaphylactic shock—Etoposide—prostate cancer	0.000125	0.00179	CcSEcCtD
Probenecid—Nausea—Goserelin—prostate cancer	0.00012	0.00173	CcSEcCtD
Probenecid—Nausea—Conjugated Estrogens—prostate cancer	0.000119	0.00171	CcSEcCtD
Probenecid—Urticaria—Mitoxantrone—prostate cancer	0.000119	0.00171	CcSEcCtD
Probenecid—Anorexia—Etoposide—prostate cancer	0.000119	0.0017	CcSEcCtD
Probenecid—Hypersensitivity—Estradiol—prostate cancer	0.000118	0.0017	CcSEcCtD
Probenecid—Body temperature increased—Mitoxantrone—prostate cancer	0.000118	0.0017	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000118	0.0017	CcSEcCtD
Probenecid—Anaemia—Docetaxel—prostate cancer	0.000117	0.00168	CcSEcCtD
Probenecid—Flushing—Prednisone—prostate cancer	0.000117	0.00167	CcSEcCtD
Probenecid—Pruritus—Estradiol—prostate cancer	0.000114	0.00163	CcSEcCtD
Probenecid—Leukopenia—Docetaxel—prostate cancer	0.000114	0.00163	CcSEcCtD
Probenecid—Anaemia—Capecitabine—prostate cancer	0.000114	0.00163	CcSEcCtD
Probenecid—Pollakiuria—Epirubicin—prostate cancer	0.000113	0.00163	CcSEcCtD
Probenecid—Alopecia—Prednisone—prostate cancer	0.000111	0.00159	CcSEcCtD
Probenecid—Hypersensitivity—Mitoxantrone—prostate cancer	0.00011	0.00158	CcSEcCtD
Probenecid—Leukopenia—Capecitabine—prostate cancer	0.00011	0.00158	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000109	0.00156	CcSEcCtD
Probenecid—Decreased appetite—Etoposide—prostate cancer	0.000108	0.00155	CcSEcCtD
Probenecid—Pain—Etoposide—prostate cancer	0.000107	0.00153	CcSEcCtD
Probenecid—Dizziness—Estradiol—prostate cancer	0.000106	0.00152	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—prostate cancer	0.000105	0.00151	CcSEcCtD
Probenecid—Haematuria—Epirubicin—prostate cancer	0.000104	0.0015	CcSEcCtD
Probenecid—Anaphylactic shock—Docetaxel—prostate cancer	0.000104	0.00149	CcSEcCtD
Probenecid—Vomiting—Estradiol—prostate cancer	0.000102	0.00147	CcSEcCtD
Probenecid—Dermatitis—Estradiol—prostate cancer	0.000101	0.00145	CcSEcCtD
Probenecid—Anaemia—Prednisone—prostate cancer	0.000101	0.00145	CcSEcCtD
Probenecid—Headache—Estradiol—prostate cancer	0.000101	0.00144	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.0001	0.00144	CcSEcCtD
Probenecid—Urticaria—Etoposide—prostate cancer	9.9e-05	0.00142	CcSEcCtD
Probenecid—Anorexia—Docetaxel—prostate cancer	9.87e-05	0.00142	CcSEcCtD
Probenecid—Body temperature increased—Etoposide—prostate cancer	9.85e-05	0.00141	CcSEcCtD
Probenecid—ABCB1—bone marrow—prostate cancer	9.73e-05	0.00211	CbGeAlD
Probenecid—Haematuria—Doxorubicin—prostate cancer	9.66e-05	0.00139	CcSEcCtD
Probenecid—Anorexia—Capecitabine—prostate cancer	9.56e-05	0.00137	CcSEcCtD
Probenecid—Nausea—Estradiol—prostate cancer	9.55e-05	0.00137	CcSEcCtD
Probenecid—Vomiting—Mitoxantrone—prostate cancer	9.53e-05	0.00137	CcSEcCtD
Probenecid—Dermatitis—Mitoxantrone—prostate cancer	9.44e-05	0.00135	CcSEcCtD
Probenecid—Headache—Mitoxantrone—prostate cancer	9.39e-05	0.00135	CcSEcCtD
Probenecid—Erythema multiforme—Epirubicin—prostate cancer	9.3e-05	0.00133	CcSEcCtD
Probenecid—Hypersensitivity—Etoposide—prostate cancer	9.18e-05	0.00132	CcSEcCtD
Probenecid—Flushing—Epirubicin—prostate cancer	9.13e-05	0.00131	CcSEcCtD
Probenecid—Decreased appetite—Docetaxel—prostate cancer	9e-05	0.00129	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisone—prostate cancer	8.93e-05	0.00128	CcSEcCtD
Probenecid—Nausea—Mitoxantrone—prostate cancer	8.9e-05	0.00128	CcSEcCtD
Probenecid—Pain—Docetaxel—prostate cancer	8.86e-05	0.00127	CcSEcCtD
Probenecid—Pruritus—Etoposide—prostate cancer	8.82e-05	0.00126	CcSEcCtD
Probenecid—Decreased appetite—Capecitabine—prostate cancer	8.72e-05	0.00125	CcSEcCtD
Probenecid—Alopecia—Epirubicin—prostate cancer	8.69e-05	0.00125	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—prostate cancer	8.6e-05	0.00123	CcSEcCtD
Probenecid—Pain—Capecitabine—prostate cancer	8.57e-05	0.00123	CcSEcCtD
Probenecid—Anorexia—Prednisone—prostate cancer	8.51e-05	0.00122	CcSEcCtD
Probenecid—Flushing—Doxorubicin—prostate cancer	8.44e-05	0.00121	CcSEcCtD
Probenecid—ABCB1—testis—prostate cancer	8.32e-05	0.0018	CbGeAlD
Probenecid—Dizziness—Etoposide—prostate cancer	8.24e-05	0.00118	CcSEcCtD
Probenecid—Body temperature increased—Docetaxel—prostate cancer	8.19e-05	0.00117	CcSEcCtD
Probenecid—Alopecia—Doxorubicin—prostate cancer	8.04e-05	0.00115	CcSEcCtD
Probenecid—Urticaria—Capecitabine—prostate cancer	7.97e-05	0.00114	CcSEcCtD
Probenecid—Body temperature increased—Capecitabine—prostate cancer	7.93e-05	0.00114	CcSEcCtD
Probenecid—Vomiting—Etoposide—prostate cancer	7.92e-05	0.00114	CcSEcCtD
Probenecid—Anaemia—Epirubicin—prostate cancer	7.91e-05	0.00113	CcSEcCtD
Probenecid—Dermatitis—Etoposide—prostate cancer	7.85e-05	0.00113	CcSEcCtD
Probenecid—Headache—Etoposide—prostate cancer	7.81e-05	0.00112	CcSEcCtD
Probenecid—Decreased appetite—Prednisone—prostate cancer	7.76e-05	0.00111	CcSEcCtD
Probenecid—Leukopenia—Epirubicin—prostate cancer	7.66e-05	0.0011	CcSEcCtD
Probenecid—Hypersensitivity—Docetaxel—prostate cancer	7.63e-05	0.00109	CcSEcCtD
Probenecid—Nausea—Etoposide—prostate cancer	7.4e-05	0.00106	CcSEcCtD
Probenecid—Hypersensitivity—Capecitabine—prostate cancer	7.39e-05	0.00106	CcSEcCtD
Probenecid—Pruritus—Docetaxel—prostate cancer	7.33e-05	0.00105	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—prostate cancer	7.32e-05	0.00105	CcSEcCtD
Probenecid—Urticaria—Prednisone—prostate cancer	7.1e-05	0.00102	CcSEcCtD
Probenecid—Pruritus—Capecitabine—prostate cancer	7.09e-05	0.00102	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—prostate cancer	7.09e-05	0.00102	CcSEcCtD
Probenecid—Body temperature increased—Prednisone—prostate cancer	7.06e-05	0.00101	CcSEcCtD
Probenecid—Anaphylactic shock—Epirubicin—prostate cancer	6.99e-05	0.001	CcSEcCtD
Probenecid—Dizziness—Docetaxel—prostate cancer	6.85e-05	0.000982	CcSEcCtD
Probenecid—Anorexia—Epirubicin—prostate cancer	6.66e-05	0.000955	CcSEcCtD
Probenecid—Dizziness—Capecitabine—prostate cancer	6.63e-05	0.000951	CcSEcCtD
Probenecid—Vomiting—Docetaxel—prostate cancer	6.59e-05	0.000944	CcSEcCtD
Probenecid—Hypersensitivity—Prednisone—prostate cancer	6.58e-05	0.000944	CcSEcCtD
Probenecid—Dermatitis—Docetaxel—prostate cancer	6.52e-05	0.000936	CcSEcCtD
Probenecid—Headache—Docetaxel—prostate cancer	6.49e-05	0.000931	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—prostate cancer	6.46e-05	0.000927	CcSEcCtD
Probenecid—Vomiting—Capecitabine—prostate cancer	6.38e-05	0.000914	CcSEcCtD
Probenecid—Pruritus—Prednisone—prostate cancer	6.32e-05	0.000906	CcSEcCtD
Probenecid—Dermatitis—Capecitabine—prostate cancer	6.32e-05	0.000906	CcSEcCtD
Probenecid—Headache—Capecitabine—prostate cancer	6.28e-05	0.000901	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—prostate cancer	6.16e-05	0.000884	CcSEcCtD
Probenecid—Nausea—Docetaxel—prostate cancer	6.15e-05	0.000882	CcSEcCtD
Probenecid—Decreased appetite—Epirubicin—prostate cancer	6.07e-05	0.000871	CcSEcCtD
Probenecid—ABCB1—lymph node—prostate cancer	6.03e-05	0.0013	CbGeAlD
Probenecid—Pain—Epirubicin—prostate cancer	5.97e-05	0.000857	CcSEcCtD
Probenecid—Nausea—Capecitabine—prostate cancer	5.96e-05	0.000854	CcSEcCtD
Probenecid—Dizziness—Prednisone—prostate cancer	5.91e-05	0.000847	CcSEcCtD
Probenecid—Vomiting—Prednisone—prostate cancer	5.68e-05	0.000814	CcSEcCtD
Probenecid—Dermatitis—Prednisone—prostate cancer	5.63e-05	0.000807	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—prostate cancer	5.62e-05	0.000806	CcSEcCtD
Probenecid—Headache—Prednisone—prostate cancer	5.6e-05	0.000803	CcSEcCtD
Probenecid—Urticaria—Epirubicin—prostate cancer	5.55e-05	0.000796	CcSEcCtD
Probenecid—Pain—Doxorubicin—prostate cancer	5.53e-05	0.000793	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—prostate cancer	5.52e-05	0.000792	CcSEcCtD
Probenecid—Nausea—Prednisone—prostate cancer	5.31e-05	0.000761	CcSEcCtD
Probenecid—Hypersensitivity—Epirubicin—prostate cancer	5.15e-05	0.000738	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—prostate cancer	5.13e-05	0.000736	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—prostate cancer	5.11e-05	0.000733	CcSEcCtD
Probenecid—Pruritus—Epirubicin—prostate cancer	4.94e-05	0.000709	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—prostate cancer	4.76e-05	0.000683	CcSEcCtD
Probenecid—Dizziness—Epirubicin—prostate cancer	4.62e-05	0.000663	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—prostate cancer	4.57e-05	0.000656	CcSEcCtD
Probenecid—Vomiting—Epirubicin—prostate cancer	4.44e-05	0.000637	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—prostate cancer	4.4e-05	0.000631	CcSEcCtD
Probenecid—Headache—Epirubicin—prostate cancer	4.38e-05	0.000628	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—prostate cancer	4.27e-05	0.000613	CcSEcCtD
Probenecid—Nausea—Epirubicin—prostate cancer	4.15e-05	0.000595	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—prostate cancer	4.11e-05	0.000589	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—prostate cancer	4.07e-05	0.000584	CcSEcCtD
Probenecid—Headache—Doxorubicin—prostate cancer	4.05e-05	0.000581	CcSEcCtD
Probenecid—Nausea—Doxorubicin—prostate cancer	3.84e-05	0.000551	CcSEcCtD
Probenecid—ABCC5—Metabolism—PIK3CA—prostate cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTA1—prostate cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CREBBP—prostate cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—EP300—prostate cancer	1.34e-06	1.43e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—COMT—prostate cancer	1.34e-06	1.42e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1B1—prostate cancer	1.33e-06	1.42e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—prostate cancer	1.33e-06	1.42e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTP1—prostate cancer	1.33e-06	1.42e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—COMT—prostate cancer	1.33e-06	1.41e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTO1—prostate cancer	1.33e-06	1.41e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NAT2—prostate cancer	1.33e-06	1.41e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.33e-06	1.41e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTP1—prostate cancer	1.32e-06	1.41e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GGT1—prostate cancer	1.32e-06	1.41e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1A—prostate cancer	1.32e-06	1.4e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—prostate cancer	1.31e-06	1.4e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.31e-06	1.4e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—prostate cancer	1.31e-06	1.4e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ITPR1—prostate cancer	1.31e-06	1.39e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NCOA1—prostate cancer	1.3e-06	1.39e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ITPR1—prostate cancer	1.3e-06	1.39e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NQO1—prostate cancer	1.3e-06	1.38e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GGT1—prostate cancer	1.29e-06	1.37e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.29e-06	1.37e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.28e-06	1.37e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.28e-06	1.36e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TH—prostate cancer	1.28e-06	1.36e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—INS—prostate cancer	1.28e-06	1.36e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CB—prostate cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PLCB2—prostate cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LRP2—prostate cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CD—prostate cancer	1.27e-06	1.35e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.27e-06	1.35e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NCOA1—prostate cancer	1.27e-06	1.35e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.26e-06	1.35e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—prostate cancer	1.26e-06	1.34e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.26e-06	1.34e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EP300—prostate cancer	1.25e-06	1.33e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP19A1—prostate cancer	1.25e-06	1.33e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CREBBP—prostate cancer	1.25e-06	1.33e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—prostate cancer	1.25e-06	1.33e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—P4HB—prostate cancer	1.25e-06	1.33e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.24e-06	1.32e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—RXRA—prostate cancer	1.24e-06	1.32e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TYMS—prostate cancer	1.24e-06	1.32e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—TYMS—prostate cancer	1.23e-06	1.31e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—prostate cancer	1.22e-06	1.3e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTM1—prostate cancer	1.22e-06	1.3e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB1—prostate cancer	1.22e-06	1.3e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—SRC—prostate cancer	1.22e-06	1.3e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTM1—prostate cancer	1.21e-06	1.29e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.21e-06	1.29e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—RXRA—prostate cancer	1.21e-06	1.29e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GGT1—prostate cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NOS3—prostate cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—LPL—prostate cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—LPL—prostate cancer	1.19e-06	1.27e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—COMT—prostate cancer	1.19e-06	1.27e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTP1—prostate cancer	1.19e-06	1.26e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NCOA1—prostate cancer	1.19e-06	1.26e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CD—prostate cancer	1.18e-06	1.26e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.18e-06	1.26e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—prostate cancer	1.17e-06	1.25e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.17e-06	1.25e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ITPR1—prostate cancer	1.17e-06	1.24e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—EP300—prostate cancer	1.17e-06	1.24e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MED12—prostate cancer	1.16e-06	1.24e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—COMT—prostate cancer	1.16e-06	1.24e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTP1—prostate cancer	1.16e-06	1.23e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.16e-06	1.23e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GNG5—prostate cancer	1.15e-06	1.23e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP1A1—prostate cancer	1.15e-06	1.23e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ERCC2—prostate cancer	1.15e-06	1.22e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.15e-06	1.22e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ERCC2—prostate cancer	1.14e-06	1.22e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ITPR1—prostate cancer	1.14e-06	1.21e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—prostate cancer	1.13e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—RXRA—prostate cancer	1.13e-06	1.2e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NOS3—prostate cancer	1.12e-06	1.19e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOA3—prostate cancer	1.11e-06	1.19e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CB—prostate cancer	1.11e-06	1.18e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TYMS—prostate cancer	1.1e-06	1.18e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—prostate cancer	1.1e-06	1.17e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—prostate cancer	1.1e-06	1.17e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.1e-06	1.17e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—prostate cancer	1.1e-06	1.17e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—prostate cancer	1.09e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTM1—prostate cancer	1.09e-06	1.16e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFB1—prostate cancer	1.09e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—COMT—prostate cancer	1.09e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTP1—prostate cancer	1.08e-06	1.15e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—MTHFR—prostate cancer	1.08e-06	1.15e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TYMS—prostate cancer	1.08e-06	1.15e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—MTHFR—prostate cancer	1.07e-06	1.14e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—LPL—prostate cancer	1.07e-06	1.14e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—prostate cancer	1.07e-06	1.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ITPR1—prostate cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTM1—prostate cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HPGDS—prostate cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARA—prostate cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.05e-06	1.12e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARA—prostate cancer	1.05e-06	1.12e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—EP300—prostate cancer	1.05e-06	1.12e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.05e-06	1.12e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—LPL—prostate cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—prostate cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.03e-06	1.1e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CB—prostate cancer	1.03e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTT1—prostate cancer	1.03e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ACHE—prostate cancer	1.03e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ERCC2—prostate cancer	1.02e-06	1.09e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—prostate cancer	1.02e-06	1.09e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—prostate cancer	1.02e-06	1.09e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.02e-06	1.08e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1A1—prostate cancer	1.01e-06	1.07e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—prostate cancer	1.01e-06	1.07e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TYMS—prostate cancer	1.01e-06	1.07e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—prostate cancer	1e-06	1.07e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ERCC2—prostate cancer	1e-06	1.07e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CAV1—prostate cancer	9.96e-07	1.06e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTM1—prostate cancer	9.94e-07	1.06e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—prostate cancer	9.9e-07	1.05e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CAV1—prostate cancer	9.9e-07	1.05e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKR1C3—prostate cancer	9.9e-07	1.05e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PRKACB—prostate cancer	9.84e-07	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—LPL—prostate cancer	9.76e-07	1.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP17A1—prostate cancer	9.74e-07	1.04e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—MTHFR—prostate cancer	9.63e-07	1.03e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—prostate cancer	9.58e-07	1.02e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.51e-07	1.01e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.46e-07	1.01e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARA—prostate cancer	9.45e-07	1.01e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1A1—prostate cancer	9.42e-07	1e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—MTHFR—prostate cancer	9.4e-07	1e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ERCC2—prostate cancer	9.34e-07	9.96e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOA2—prostate cancer	9.28e-07	9.89e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—prostate cancer	9.26e-07	9.87e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARA—prostate cancer	9.22e-07	9.83e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—EP300—prostate cancer	9.13e-07	9.73e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CG—prostate cancer	9.07e-07	9.66e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CG—prostate cancer	9.02e-07	9.61e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—prostate cancer	8.92e-07	9.51e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CAV1—prostate cancer	8.89e-07	9.47e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC5A5—prostate cancer	8.86e-07	9.44e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—MTHFR—prostate cancer	8.78e-07	9.36e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CAV1—prostate cancer	8.67e-07	9.24e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2E1—prostate cancer	8.65e-07	9.22e-06	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—prostate cancer	8.62e-07	9.19e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARA—prostate cancer	8.62e-07	9.18e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—INS—prostate cancer	8.58e-07	9.15e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NQO1—prostate cancer	8.55e-07	9.11e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—INS—prostate cancer	8.54e-07	9.1e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—EP300—prostate cancer	8.51e-07	9.07e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.49e-07	9.05e-06	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—prostate cancer	8.49e-07	9.04e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TH—prostate cancer	8.43e-07	8.98e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CREBBP—prostate cancer	8.41e-07	8.96e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—CREBBP—prostate cancer	8.36e-07	8.91e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—prostate cancer	8.2e-07	8.74e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.2e-07	8.74e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CAV1—prostate cancer	8.1e-07	8.63e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CG—prostate cancer	8.09e-07	8.63e-06	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—prostate cancer	8.09e-07	8.62e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CD—prostate cancer	7.97e-07	8.5e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GGT1—prostate cancer	7.94e-07	8.46e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CD—prostate cancer	7.93e-07	8.45e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CG—prostate cancer	7.9e-07	8.42e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOA1—prostate cancer	7.82e-07	8.34e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—prostate cancer	7.76e-07	8.27e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.74e-07	8.25e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP19A1—prostate cancer	7.71e-07	8.22e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—INS—prostate cancer	7.66e-07	8.16e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—prostate cancer	7.57e-07	8.06e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NOS3—prostate cancer	7.53e-07	8.02e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CREBBP—prostate cancer	7.5e-07	8e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—NOS3—prostate cancer	7.48e-07	7.98e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—INS—prostate cancer	7.48e-07	7.97e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—RXRA—prostate cancer	7.44e-07	7.93e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.38e-07	7.86e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CREBBP—prostate cancer	7.32e-07	7.81e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—COMT—prostate cancer	7.17e-07	7.64e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTP1—prostate cancer	7.13e-07	7.6e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CD—prostate cancer	7.12e-07	7.58e-06	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—prostate cancer	7.04e-07	7.5e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ITPR1—prostate cancer	7.02e-07	7.48e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—INS—prostate cancer	6.99e-07	7.44e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CB—prostate cancer	6.95e-07	7.4e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CD—prostate cancer	6.95e-07	7.4e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CB—prostate cancer	6.91e-07	7.36e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—prostate cancer	6.88e-07	7.34e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—prostate cancer	6.85e-07	7.3e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CREBBP—prostate cancer	6.84e-07	7.29e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—prostate cancer	6.75e-07	7.2e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NOS3—prostate cancer	6.72e-07	7.16e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TYMS—prostate cancer	6.63e-07	7.07e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NOS3—prostate cancer	6.56e-07	6.99e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTM1—prostate cancer	6.55e-07	6.99e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.49e-07	6.91e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LPL—prostate cancer	6.43e-07	6.86e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—prostate cancer	6.34e-07	6.75e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—prostate cancer	6.3e-07	6.71e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.21e-07	6.62e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.2e-07	6.61e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ERCC2—prostate cancer	6.16e-07	6.57e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—prostate cancer	6.15e-07	6.55e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NOS3—prostate cancer	6.13e-07	6.53e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CB—prostate cancer	6.05e-07	6.45e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—prostate cancer	6e-07	6.4e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—prostate cancer	6e-07	6.39e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—prostate cancer	5.97e-07	6.36e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTHFR—prostate cancer	5.79e-07	6.17e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—EP300—prostate cancer	5.73e-07	6.1e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—EP300—prostate cancer	5.69e-07	6.07e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARA—prostate cancer	5.68e-07	6.06e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.66e-07	6.03e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—prostate cancer	5.6e-07	5.97e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—prostate cancer	5.52e-07	5.88e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—prostate cancer	5.36e-07	5.71e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CAV1—prostate cancer	5.34e-07	5.69e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—prostate cancer	5.23e-07	5.57e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—prostate cancer	5.14e-07	5.48e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—EP300—prostate cancer	5.11e-07	5.45e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—EP300—prostate cancer	4.99e-07	5.32e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—prostate cancer	4.89e-07	5.21e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.87e-07	5.19e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—EP300—prostate cancer	4.66e-07	4.97e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—INS—prostate cancer	4.61e-07	4.91e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CREBBP—prostate cancer	4.51e-07	4.81e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.28e-07	4.56e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.24e-07	4.51e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—prostate cancer	4.21e-07	4.49e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NOS3—prostate cancer	4.04e-07	4.31e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.78e-07	4.03e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.73e-07	3.97e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—prostate cancer	3.7e-07	3.94e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—prostate cancer	3.69e-07	3.93e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—prostate cancer	3.46e-07	3.69e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.45e-07	3.67e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—prostate cancer	3.44e-07	3.67e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—prostate cancer	3.22e-07	3.43e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—prostate cancer	3.09e-07	3.29e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—EP300—prostate cancer	3.07e-07	3.28e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—prostate cancer	3.01e-07	3.21e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—prostate cancer	2.82e-07	3e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.27e-07	2.42e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—prostate cancer	1.86e-07	1.98e-06	CbGpPWpGaD
